2022-07-01 SC083609 2023-06-30 SC083609 2022-07-01 2023-06-30 SC083609 2022-06-30 SC083609 2021-07-01 2022-06-30 SC083609 uk-core:WithinOneYear 2022-06-30 SC083609 uk-core:WithinOneYear 2023-06-30 SC083609 uk-core:AfterOneYear 2022-06-30 SC083609 uk-core:AfterOneYear 2023-06-30 SC083609 uk-core:ShareCapital 2023-06-30 SC083609 uk-core:ShareCapital 2022-06-30 SC083609 uk-core:RetainedEarningsAccumulatedLosses 2023-06-30 SC083609 uk-core:RetainedEarningsAccumulatedLosses 2022-06-30 SC083609 uk-bus:Director1 2022-07-01 2023-06-30 SC083609 uk-core:PlantMachinery 2022-07-01 2023-06-30 SC083609 uk-core:ToolsEquipment 2022-07-01 2023-06-30 SC083609 uk-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2022-06-30 SC083609 uk-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2022-07-01 2023-06-30 SC083609 uk-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-06-30 SC083609 uk-core:ToolsEquipment 2022-06-30 SC083609 uk-core:PlantMachinery 2022-06-30 SC083609 uk-core:PlantMachinery 2023-06-30 SC083609 uk-core:ToolsEquipment 2023-06-30 SC083609 uk-core:WithinOneYear 2023-06-30 SC083609 uk-core:WithinOneYear 2022-06-30 SC083609 uk-core:AfterOneYear uk-core:Secured 2023-06-30 SC083609 uk-core:AfterOneYear uk-core:Secured 2022-06-30 iso4217:GBP xbrli:pure SC083609 uk-bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 SC083609 uk-bus:FRS102 2022-07-01 2023-06-30 SC083609 uk-bus:FilletedAccounts 2022-07-01 2023-06-30 SC083609 uk-bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30
Calscience International Limited
Registered Number:SC083609
For the year ended 30 June 2023
Scotland
Unaudited Financial Statements
2
For the year ended 30 June 2023
Calscience International Limited
Contents Page
1
Statement of Financial Position
2 to 5
Notes to the Financial Statements
3
Registered Number :
SC083609
As at 30 June 2023
Calscience International Limited
Statement of Financial Position
£
£
2022
2023
Notes
Fixed assets
Intangible assets
648,039
632,969
2
Property, plant and equipment
3
3
3
648,042
632,972
Current assets
Inventories
20,920
20,920
4
Trade and other receivables
9,594
2,337
5
170
Cash and cash equivalents
170
23,427
30,684
Trade and other payables: amounts falling due within one year
(554,002)
(574,079)
6
(523,318)
(550,652)
Net current liabilities
Total assets less current liabilities
97,390
109,654
Trade and other payables: amounts falling due after more than
one year
(71,328)
(66,741)
7
30,649
Net assets
38,326
Capital and reserves
Called up share capital
200,000
200,000
Retained earnings
(169,351)
(161,674)
30,649
38,326
Shareholders' funds
For the year ended 30 June 2023 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
I W G Forbes Director
These financial statements were approved and authorised for issue by the Board on 28 February 2024 and were signed by:
1 of 5
4
Registered Number :
SC083609
For the year ended 30 June 2023
Calscience International Limited
Statement of Financial Position Continued
The notes form part of these financial statements
2 of 5
5
For the year ended 30 June 2023
Calscience International Limited
Notes to the Financial Statements
Statutory Information
Calscience International Limited is a private limited company, limited by shares, domiciled in Scotland, registration number
SC083609.
Registered address:
4th Floor
115 George Street
Edinburgh
EH2 4JN
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting
Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
The financial statements have been prepared under the historical costs convention as modified by the revaluation of certain
assets.
Research and development
Research and development expenditure is charged to the profit and loss account in the period in which it is incurred except where:a) it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity; andb) the cost or value of the asset can be measured reliably.
Property, plant and equipment
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and machinery
20% Straight line
33% Straight line
Computer equipment
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the profit and loss account over the expected useful life of the assets. Grants received towards revenue expenditure are released to the profit and loss account as the related expenditure is incurred.
Inventories
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme for the benefit of its directors/and employees. Contributions payable are charged to the profit and loss account in the period in which they are payable.
2. Intangible fixed assets
Research &
Development
Cost or valuation
£
At 01 July 2022
632,969
Additions
15,070
At 30 June 2023
648,039
3 of 5
6
For the year ended 30 June 2023
Calscience International Limited
Notes to the Financial Statements Continued
3. Property, plant and equipment
Total
Computer
equipment
Plant and
machinery
£
£
£
Cost or valuation
At 01 July 2022
16,733
651
16,082
At 30 June 2023
16,082
651
16,733
Provision for depreciation and impairment
At 01 July 2022
16,730
649
16,081
At 30 June 2023
16,730
649
16,081
At 30 June 2023
Net book value
1
2
3
At 30 June 2022
1
2
3
4. Inventories
2022
2023
£
£
Stocks
20,920
20,920
5. Trade and other receivables
2022
2023
£
£
Other debtors
2,337
9,594
6. Trade and other payables: amounts falling due within one year
2022
2023
£
£
Bank loans and overdraft
26,276
13,776
Trade creditors
56,968
71,194
Amounts owed to group undertaking and undertaking in which the company
has a participating interest
471,371
451,338
Taxation and social security
1,169
1,169
Other creditors
18,295
16,525
574,079
554,002
4 of 5
7
For the year ended 30 June 2023
Calscience International Limited
Notes to the Financial Statements Continued
7. Trade and other payables: amounts falling due after more than one year
2022
2023
£
£
Bank loans and overdraft
15,413
20,000
Other creditors
51,328
51,328
66,741
71,328
8. Average number of persons employed
During the year the average number of employees was 2.
9. Transition to FRS 102
The principal accounting polices applied in the preparation of the financial statements are set out above. These policies have
been consistently applied to all the years presented, unless otherwise stated. No changes have arisen as a result of the
transition to Section 1A of Financial Reporting Standard 102.
5 of 5